Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 ,inter alia, to consider and approve 1) To increase authorised share capital of the Company in accordance with Companies Act, 2013 and subject to any regulatory/ statutory approvals, as may be required and the approval of the shareholders of the Company;2) To consider and if thought fit, approve the issuance of equity shares / convertible warrants of the Company on a preferential basis in accordance with the Companies Act, 2013 read with the rules notified thereunder, each as amended, and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and such other acts, rules and regulations, as may be applicable, subject to any regulatory/ statutory approvals, as may be required and the approval of the shareholders of the Company;and other items.